Odyssey Therapeutics ODTX
NASDAQ ODTX
$19.36 +0.22 (+1.15%)
At close: Nov 16, 2026 · 4:00 PM EST

Odyssey Therapeutics (ODTX) EBIT Margin (2023 - 2025)

Updated

Odyssey Therapeutics (ODTX) reported EBIT Margin of -5279.20% for FY2025, down 2215.22 percentage points from -3063.98% in FY2024.

Analysis

Odyssey Therapeutics (ODTX) EBIT Margin (2023 - 2025) Analysis & Trends

  • According to Business Quant data, EBIT Margin came in at -3063.98% in FY2024 (+9832.46 pp) and -12896.43% in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 24.35%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 36.01%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 30.74%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 29.12%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 35.79%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 41.71%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 32.98%
10 Odyssey Therapeutics 929.15 Mn -64.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -38,640.40%
Jun 30, 2025 -4,371.32%
Mar 31, 2025 -2,041.71%
Dec 31, 2024 -2,136.98%
Dec 31, 2023 -10,867.60%
API Access

Odyssey Therapeutics EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=ODTX&period=max&api_key=YOUR_API_KEY